Skip To Main Content
van Barreveld on Muck Rack

van Barreveld

As seen in: Biomed Central (BMC)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with van

Contact van, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema | Trials | Full

|
By van Barreveld, van Enst, Dirk Jan, Maritza Albertina
| Biomed Central (BMC)
Correction: The UPDATE trial (UVB Phototherapy in Dermatology for Atopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema Correction Open access Published: 17 February 2025 Trials volume 26, Article number: 55 (2025) Cite this article The Original Article was published on 16 July 2024 Correction: Trials 25, 482 (2025) https://doi.org/10.1186/s13063-024-08334-z Following the...
Open in Who Shared Issue with article?

The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema | Trials | Full Text

|
By van Enst, Dirk Jan, Amsterdam UMC, van Barreveld
| Biomed Central (BMC)
Atopic eczema (AE) (syn. atopic dermatitis) is a dermatological condition characterized by a chronic fluctuating pruritic inflammation of the skin. It is a common disease that affects 2–10% of the adult population, thereby posing a high burden in terms of health care costs [1,2,3].
Open in Who Shared Issue with article?
See all 2 articles